289 related articles for article (PubMed ID: 31939441)
21. Combined positron emission tomography/computed tomography for diagnosis and monitoring of orbital adnexal lymphoma.
Klingenstein A; Garip-Kuebler A; Mueller-Lisse UG; Hintschich C
Acta Ophthalmol; 2018 Sep; 96(6):e712-e717. PubMed ID: 30146694
[TBL] [Abstract][Full Text] [Related]
22. Utility of FDG-PET in predicting the histology of relapsed or refractory lymphoma.
Wai SH; Lee ST; Cliff ERS; Bei M; Lee J; Hawkes EA; Chong G
Blood Adv; 2024 Feb; 8(3):736-745. PubMed ID: 38127277
[TBL] [Abstract][Full Text] [Related]
23. Correlation between
Zhao J; Wang H
J Med Imaging Radiat Oncol; 2021 Apr; 65(2):188-194. PubMed ID: 33538120
[TBL] [Abstract][Full Text] [Related]
24. The correlation of
Qu YH; Long N; Ran C; Sun J
Clin Transl Oncol; 2021 Mar; 23(3):620-627. PubMed ID: 32683540
[TBL] [Abstract][Full Text] [Related]
25. Whole-body diffusion-weighted MRI and (18)F-FDG PET/CT can discriminate between different lymphoma subtypes.
Mosavi F; Wassberg C; Selling J; Molin D; Ahlström H
Clin Radiol; 2015 Nov; 70(11):1229-36. PubMed ID: 26208992
[TBL] [Abstract][Full Text] [Related]
26. 18F-FDG or 3'-deoxy-3'-18F-fluorothymidine to detect transformation of follicular lymphoma.
Wondergem MJ; Rizvi SN; Jauw Y; Hoekstra OS; Hoetjes N; van de Ven PM; Boellaard R; Chamuleau ME; Cillessen SA; Regelink JC; Zweegman S; Zijlstra JM
J Nucl Med; 2015 Feb; 56(2):216-21. PubMed ID: 25593118
[TBL] [Abstract][Full Text] [Related]
27. Comparison of 99mTc-methyl diphosphonate bone scintigraphy and 18F-fluorodeoxyglucose positron emission tomography/computed tomography to predict histologic response to neoadjuvant chemotherapy in patients with osteosarcoma.
Lee I; Byun BH; Lim I; Kim BI; Kong CB; Song WS; Cho WH; Koh JS; Lim SM
Medicine (Baltimore); 2018 Sep; 97(37):e12318. PubMed ID: 30212975
[TBL] [Abstract][Full Text] [Related]
28. Correlation of 18F-FDG PET/CT SUVmax with clinical features, D-dimer and LDH in patients with primary intestinal lymphoma.
Zhou S; Chen W; Lin M; Chen G; Chen C; Huo C; Du X
J Int Med Res; 2021 Jul; 49(7):3000605211029809. PubMed ID: 34250823
[TBL] [Abstract][Full Text] [Related]
29. The maximum standardized uptake value of metastatic site in 18 F-FDG PET/CT predicts molecular subtypes and survival in metastatic breast cancer: An Izmir Oncology Group study.
Cokmert S; Tanriverdi O; Karapolat I; Demir L; Bayoglu V; Can A; Akyol M; Yilmaz Y; Oktay Tarhan M
J BUON; 2016; 21(6):1410-1418. PubMed ID: 28039701
[TBL] [Abstract][Full Text] [Related]
30. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
31. High SUV uptake on FDG-PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET/CT staging in lymphoma.
Ngeow JYY; Quek RHH; Ng DCE; Hee SW; Tao M; Lim LC; Tan YH; Lim ST
Ann Oncol; 2009 Sep; 20(9):1543-1547. PubMed ID: 19474116
[TBL] [Abstract][Full Text] [Related]
32. 18F-FDG PET/CT in gastric MALT lymphoma: a bicentric experience.
Albano D; Bertoli M; Ferro P; Fallanca F; Gianolli L; Picchio M; Giubbini R; Bertagna F
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):589-597. PubMed ID: 27619357
[TBL] [Abstract][Full Text] [Related]
33. Correlation of
Mitamura K; Yamamoto Y; Norikane T; Hatakeyama T; Okada M; Nishiyama Y
Ann Nucl Med; 2018 Nov; 32(9):627-633. PubMed ID: 30032455
[TBL] [Abstract][Full Text] [Related]
34. SUVmax in FDG-PET at the biopsy site correlates with the proliferation potential of tumor cells in non-Hodgkin lymphoma.
Watanabe R; Tomita N; Takeuchi K; Sakata S; Tateishi U; Tanaka M; Fujita H; Inayama Y; Ishigatsubo Y
Leuk Lymphoma; 2010 Feb; 51(2):279-83. PubMed ID: 20038236
[TBL] [Abstract][Full Text] [Related]
35. Multiple metabolic parameters and visual assessment of
Ren Y; Liu J; Wang L; Luo Y; Ding X; Shi A; Liu J
Abdom Radiol (NY); 2020 Nov; 45(11):3569-3580. PubMed ID: 32274551
[TBL] [Abstract][Full Text] [Related]
36. Correlation of mean apparent diffusion coefficient (ADC) and maximal standard uptake value (SUVmax) evaluated by diffusion-weighted MRI and 18F-FDG-PET/CT in children with Hodgkin lymphoma: a feasibility study.
Rosbach N; Fischer S; Koch V; Vogl TJ; Bochennek K; Lehrnbecher T; Mahmoudi S; Grünewald L; Grünwald F; Bernatz S
Radiol Oncol; 2023 Jun; 57(2):150-157. PubMed ID: 37341195
[TBL] [Abstract][Full Text] [Related]
37. Common malignant brain tumors: can 18F-FDG PET/CT aid in differentiation?
Purandare NC; Puranik A; Shah S; Agrawal A; Gupta T; Moiyadi A; Shetty P; Shridhar E; Jalali R; Rangarajan V
Nucl Med Commun; 2017 Dec; 38(12):1109-1116. PubMed ID: 28922334
[TBL] [Abstract][Full Text] [Related]
38. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma].
Ding CY; Guo Z; Sun J; Yang WP; Li TR
Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):528-533. PubMed ID: 30060362
[No Abstract] [Full Text] [Related]
39. Prognostic significance of the standardized uptake value of pre-therapeutic (18)F-FDG PET in patients with malignant lymphoma.
Ahmadzadehfar H; Rodrigues M; Zakavi R; Knoll P; Mirzaei S
Med Oncol; 2011 Dec; 28(4):1570-6. PubMed ID: 20524086
[TBL] [Abstract][Full Text] [Related]
40. Volume-based parameters on FDG PET may predict the proliferative potential of soft-tissue sarcomas.
Kitao T; Shiga T; Hirata K; Sekizawa M; Takei T; Yamashiro K; Tamaki N
Ann Nucl Med; 2019 Jan; 33(1):22-31. PubMed ID: 30196378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
